D-070
N-Desmethylolanzapine-d8 dihydrochloride solution
100 μg/mL in acetonitrile: water (1:1) (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Manufacturer: Supelco
Synonym(S): N-Desmethylolanzapine-D8 dihydrochloride solution
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 ML | D-070-1-ML | In Stock | ₹ 13,563.73 |
D-070 - 1 ML
In Stock
Quantity
1
Base Price: ₹ 13,563.73
GST (18%): ₹ 2,441.471
Total Price: ₹ 16,005.201
grade
certified reference material
Quality Level
300
form
liquid
feature
Snap-N-Spike®/Snap-N-Shoot®
packaging
ampule of 1 mL
manufacturer/tradename
Cerilliant®
concentration
100 μg/mL in acetonitrile: water (1:1) (as free base)
technique(s)
gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s)
clinical testing
format
single component solution
Related Products
Description
- General description: A stable-labeled internal standard for use in LC/MS or GC/MS applications including clinical toxicology analysis, therapeutic drug monitoring, or isotope dilution methods. Desmethylolanzapine is the primary metabolite of olanzapine, marketed as the atypical antipsychotic Zyprexa® for the treatment of schizophrenia and bipolar disorder.
- Application: Monitoring Metabolic Parameters in Schizophrenia: A study utilized plasma levels of olanzapine and its metabolite, N-desmethyl-olanzapine, to monitor metabolic parameters in patients with schizophrenia, providing a critical link between antipsychotic drug concentrations and metabolic health. This research supports the use of these biomarkers in clinical settings to optimize therapeutic strategies and manage side effects (Lu et al., 2018).Evaluating Clinical Efficacy in Schizophrenia: Another significant study applied plasma levels of olanzapine and N-desmethyl-olanzapine to assess clinical efficacy in schizophrenia patients. By correlating drug levels with therapeutic outcomes, this approach aids in personalized medicine, ensuring patients receive optimal dosages for effective treatment (Lu et al., 2016).
- Legal Information: CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P210 - P233 - P240 - P241 - P301 + P312 - P305 + P351 + P338
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
WGK
WGK 2
Flash Point(F)
closed cup
Flash Point(C)
closed cup
Compare Similar Items
Show Difference
grade: certified reference material
Quality Level: 300
form: liquid
feature: Snap-N-Spike®/Snap-N-Shoot®
packaging: ampule of 1 mL
manufacturer/tradename: Cerilliant®
concentration: 100 μg/mL in acetonitrile: water (1:1) (as free base)
technique(s): gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s): clinical testing
format: single component solution
grade:
certified reference material
Quality Level:
300
form:
liquid
feature:
Snap-N-Spike®/Snap-N-Shoot®
packaging:
ampule of 1 mL
manufacturer/tradename:
Cerilliant®
concentration:
100 μg/mL in acetonitrile: water (1:1) (as free base)
technique(s):
gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s):
clinical testing
format:
single component solution
grade: certified reference material
Quality Level: 300
form: liquid
feature: Snap-N-Spike®/Snap-N-Shoot®
packaging: ampule of 1 mL
manufacturer/tradename: Cerilliant®
concentration: 100 μg/mL in methanol
technique(s): gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s): clinical testingclinical testing
format: single component solution
grade:
certified reference material
Quality Level:
300
form:
liquid
feature:
Snap-N-Spike®/Snap-N-Shoot®
packaging:
ampule of 1 mL
manufacturer/tradename:
Cerilliant®
concentration:
100 μg/mL in methanol
technique(s):
gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s):
clinical testingclinical testing
format:
single component solution
grade: certified reference material
Quality Level: 300
form: liquid
feature: Snap-N-Spike®/Snap-N-Shoot®
packaging: ampule of 1 mL
manufacturer/tradename: Cerilliant®
concentration: 100 μg/mL in methanol
technique(s): gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s): clinical testingclinical testing
format: single component solution
grade:
certified reference material
Quality Level:
300
form:
liquid
feature:
Snap-N-Spike®/Snap-N-Shoot®
packaging:
ampule of 1 mL
manufacturer/tradename:
Cerilliant®
concentration:
100 μg/mL in methanol
technique(s):
gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s):
clinical testingclinical testing
format:
single component solution
grade: certified reference material
Quality Level: 300
form: liquid
feature: Snap-N-Spike®/Snap-N-Shoot®
packaging: ampule of 1 mL
manufacturer/tradename: Cerilliant®
concentration: 100 μg/mL in methanol
technique(s): gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s): clinical testingclinical testing
format: single component solution
grade:
certified reference material
Quality Level:
300
form:
liquid
feature:
Snap-N-Spike®/Snap-N-Shoot®
packaging:
ampule of 1 mL
manufacturer/tradename:
Cerilliant®
concentration:
100 μg/mL in methanol
technique(s):
gas chromatography (GC): suitableliquid chromatography (LC): suitable
application(s):
clinical testingclinical testing
format:
single component solution